Showing results (121-130 of 781) with videos related to
Sort By:
Pageof 79
Cancers|January 13, 2021
Signaling Pathway Mediating Myeloma Cell Growth and SurvivalTeru Hideshima, Kenneth C AndersonExpert Opinion on Drug Metabolism & Toxicology|July 16, 2008
Thalidomide in multiple myeloma--clinical trials and aspects of drug metabolism and toxicityIris Breitkreutz, Kenneth C AndersonHematology/Oncology Clinics of North America|November 13, 2007
Preclinical studies of novel targeted therapiesTeru Hideshima, Kenneth C AndersonCancer Journal (Sudbury, Mass.)|January 30, 2019
Contribution of Inhibition of Protein Catabolism in MyelomaGiada Bianchi, Kenneth C AndersonNature Reviews. Cancer|December 3, 2002
Molecular mechanisms of novel therapeutic approaches for multiple myelomaTeru Hideshima, Kenneth C AndersonCell Cycle (Georgetown, Tex.)|March 14, 2007
Inhibition of VEGF signaling pathways in multiple myeloma and other malignanciesKlaus Podar, Kenneth C AndersonExpert Opinion on Therapeutic Targets|May 26, 2011
CCR1 as a target for multiple myelomaSonia Vallet, Kenneth C AndersonImmunotherapy|October 15, 2011
Intrinsic modulation of lymphocyte function by stromal cell network: advance in therapeutic targeting of cancerGüllü Görgün, Kenneth C AndersonCancer Research|October 3, 2003
Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3'-kinase/AKT signalingYu-Tzu Tai, Klaus Podar, Laurence Catley, et al.Blood|August 5, 2009
Aurora kinase A is a target of Wnt/beta-catenin involved in multiple myeloma disease progressionJui Dutta-Simmons, Yunyu Zhang, Gullu Gorgun, et al.Pageof 79